Generic Biosimilar Medicines Association
Making Medicines Affordable
Home
About GBMA
Contact us
GBMA Members
Guiding principles
Code of Practice
Code Complaint Committee
Event Reporting
Educational Events
Non-Price Benefit Reports
Annual Review
2011
2012
2013
2014
2015
2016
2017
2018
2019
Lodging a complaint
Media Enquiries
Our Objectives
Links
Advocacy
Extended Strategic Agreement
Generic Medicines Working Group (GMWG)
Submissions
Generics
Facts and Fallacies
Key Figures on Generic Medicines
What is a Generic Medicine?
Bioequivalence Explained
Biosimilars
IGBA Global Biosimilars Week
GBMA Position on Biosimilars
Impact of Biosimilars
Switching
Pharmacy Substitution
Regulation
Awareness and Uptake
Naming
Key Figures on Biosimilars
Topics
IGBA
Price Disclosure
Intellectual Property
International Trade Agreements
News
News 2020
News 2019
News 2018
News 2017
News 2016
News 2015
News 2014
GBMA Education
COVID-19 Virus
COVID-19 Virus: The Facts
You are here:
Home
/
Biosimilars
/
GBMA Position on Biosimilars
/
Key Figures on Biosimilars
Key Figures on Biosimilars
View PDF file
